Hollow silica nanospheres and methods of making same

LIPID-COATED POLYMER PARTICLES FOR IMMUNE STIMULATION

Glycopeptide constructs and uses thereof

SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES

IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

HIV POLYNUCLEOTIDES AND POLYPEPTIDES DERIVED FROM BOTSWANA MJ4

PEPTIDE CONJUGATE COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE

Immunomodulatory agent-polymeric compounds

TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS

Therapeutic and vaccine polyelectrolyte nanoparticle compositions

Stereoisomer peptides and their polymer conjugates for HIV disease

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE

Combination adjuvant formulation

Immunonanotherapeutics that provide IgG humoral response without T-cell antigen

Immunotherapy against several tumors including neuronal and brain tumors

Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides

Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides

Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides

Determining and reducing immunoresistance to a toxin therapy using toxin B peptides

POLYMER PARTICLES BASED VACCINE

Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides

Nanoparticles for immunotherapy

Amyloid-beta polypeptide vaccine

Controlled-release immunogenic formulations to modulate immune response

Conjugates of an anti-TNF-α antibody

PEGylated Aβ fab

INFLUENZA VACCINES WITH REDUCED AMOUNT OF EMULSION ADJUVANT

PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF

HIV VACCINE FORMULATIONS

Multilayer films, coatings, and microcapsules comprising polypeptides

HIV polynucleotides and polypeptides derived from Botswana MJ4

Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions

Compositions and methods for the prevention and treatment of autoimmune conditions

Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector

Use of microparticles combined with submicron oil-in-water emulsions

Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease

Non-Natural Amino Acid Polypeptides Having Modified Immunogenicity

Bioactive molecular matrix and methods of use in the treatment of disease

MIXTURES OF DRUG-OLIGOMER CONJUGATES COMPRISING POLYETHYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME

CHEMICALLY-DEFINED NON-POLYMERIC VALENCY PLATFORM MOLECULES AND CONJUGATES THEREOF

Encapsulated amyloid-beta peptides

Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof

Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides

METHODS AND COMPOSITIONS FOR INCREASED PRIMING OF T-CELLS THROUGH CROSS-PRESENTATION OF EXOGENOUS ANTIGENS

Vaccine delivery compositions and methods of use

Antigen Delivery Compositions And Methods Of Use

Inhibition of Xenoreactive Antibodies

DETERMINING AND REDUCING IMMUNORESISTANCE TO A BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN B PEPTIDES

Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist

Scaffolds for cell transplantation

Nanoparticles for immunotherapy

Microparticles for delivery of heterologous nucleic acids

Method for improving memory in AD patients

Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides

Tolerogizing compositions comprising botulinum toxin type B peptides

Chemically-defined non-polymeric valency platform molecules and conjugates thereof

Mucosal boosting following parenteral priming

Covalent attachment of ligands to nucleophilic proteins guided by non-covalent

Multilayer films, coatings, and microcapsules comprising polypeptides

Immunogenic compositions and methods of use

Hiv polynucleotides and polypeptides derived from botswana mj4

Method for production of bioresorable microparticles, microparticles thus obtained and use thereof

Methods for genetic immunization

Vaccine delivery compositions and methods of use

Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same

Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements

Hiv vaccine formulations

Methods and compositions comprising supramolecular constructs

Antigen delivery compositions and methods of use

Microparticles with adsorbed polypeptide-containing molecules

aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies

Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule

Novel method for down-regulation of amyloid

Use of microparticles combined with submicron oil-in-water emulsions

Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same

Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule

Chemically defined non-polymeric valency platform molecules and conjugates thereof